D.C. Federal Judge: FDA Disregarded Approval Timelines Under FDCA
WASHINGTON, D.C. — In a Sept. 15 opinion, a federal judge in the District of Columbia indicated that although he agrees that new chemical entity (NCE) exclusivity status does not bar...To view the full article, register now.
Already a subscriber? Click here to view full article